A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.
Sci Immunol
; 6(61)2021 07 15.
Article
in En
| MEDLINE
| ID: mdl-34266981
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adjuvants, Immunologic
/
Saccharomycetales
/
Alum Compounds
/
Spike Glycoprotein, Coronavirus
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Male
Language:
En
Journal:
Sci Immunol
Year:
2021
Document type:
Article
Affiliation country:
Country of publication: